What is ClearPoint Neuro?
ClearPoint Neuro Inc operates at the intersection of advanced medical engineering and neurosurgery. The company specializes in the development and commercialization of sophisticated platforms designed for minimally invasive surgical procedures within the brain. Its core technology suite provides neurosurgeons with high-precision navigation and delivery systems, facilitating real-time MRI guidance during complex interventions. These solutions are critical for a variety of therapeutic applications, including deep brain stimulation, laser ablation, biopsy procedures, and targeted drug delivery. By enhancing surgical accuracy and improving patient outcomes, ClearPoint Neuro serves as a vital partner to medical institutions aiming to treat complex neurological conditions with greater efficacy and safety.
How much funding has ClearPoint Neuro raised?
ClearPoint Neuro has raised a total of $180.5M across 6 funding rounds:
Debt
$1.3M
Debt
$350K
Debt
$7.5M
Stock Offering
$43.4M
Other Financing Round
$110M
Stock/Share Issuance
$17.9M
Debt (2011): $1.3M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2020): $7.5M supported by Petrichor Healthcare Capital Management
Stock Issuance/Offering (2021): $43.4M, investors not publicly disclosed
Other Financing Round (2025): $110M backed by Oberland Capital
Stock/Share Issuance (2026): $17.9M, investors not publicly disclosed
Key Investors in ClearPoint Neuro
Oberland Capital
Oberland Capital is a private investment firm focused on funding innovation in the global healthcare industry, managing approximately $3 billion in assets. The firm specializes in flexible investment structures tailored to meet the specific needs of its partners, offering a range of financing solutions including monetization of royalty streams and project-based financing.
Petrichor Healthcare Capital Management
Petrichor Healthcare Capital Management is a specialized investment firm that provides strategic capital and operational expertise to healthcare companies, focusing on long-term value creation in the medical technology and life sciences sectors.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for ClearPoint Neuro?
With the successful completion of this recent financing, ClearPoint Neuro is poised to accelerate its strategic roadmap, focusing on the expansion of its clinical footprint and the continued refinement of its image-guided neurosurgery portfolio. The company is expected to prioritize the scaling of its commercial infrastructure to meet the rising demand for advanced neuro-interventional tools. Furthermore, the capital will likely support ongoing research and development initiatives aimed at broadening the therapeutic applications of its navigation systems. As the firm transitions into this next phase of growth, it remains focused on maintaining its competitive edge in the medical device market through innovation, strategic partnerships, and a commitment to improving the standard of care for patients suffering from neurological disorders.
See full ClearPoint Neuro company page
